The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 03, 2007
Filed:
Jan. 06, 2004
Mohammad R. Marzabadi, Ridgewood, NJ (US);
John M. Wetzel, Athens, OH (US);
Chien-an Chen, Fresh Meadows, NY (US);
Yu Jiang, Jersey City, NJ (US);
Kai LU, Elmwood Park, NJ (US);
Mohammad R. Marzabadi, Ridgewood, NJ (US);
John M. Wetzel, Athens, OH (US);
Chien-An Chen, Fresh Meadows, NY (US);
Yu Jiang, Jersey City, NJ (US);
Kai Lu, Elmwood Park, NJ (US);
H. Lundbeck A/S, Copenhagen-Valby, DK;
Abstract
This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of reducing the body mass of a subject which comprises administering to the subject an amount of a compound of the invention effective to reduce the body mass of the subject. This invention further provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject's depression and/or anxiety.